China Pharma Awaits 15 Drug Patent Expirations In 2013
This article was originally published in PharmAsia News
Executive Summary
This year at least 15 drugs with sales totaling $29 billion will reach their patent expirations, including Novartis AG’s Zometa, Johnson & Johnson’s Epoetin Alfa, Abbott’s Niaspan and Roche’s Xeloda.